EUVIMEDEUVIMED entdecken
Open Access

Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach

Zeinab Dehghan, Seyed Amir Mirmotalebisohi, Maryam Mozafar, Marzieh Sameni, Fatemeh Saberi, Amin Derakhshanfar, Javad Moaedi, Hassan Zohrevand, Hakimeh Zali

DARU Journal of Pharmaceutical Sciences · 2024

DOI: 10.1007/s40199-024-00507-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift DARU Journal of Pharmaceutical Sciences, 2024. Verfasst von Zeinab Dehghan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comparative Biomedical Sciences, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, I…. Hauptthemen laut MEDLINE: Drug Repositioning, SARS-CoV-2, Protein Interaction Maps, Systems Biology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Identifying the molecular mechanisms behind SARS-CoV-2 disparities and similarities will help find new treatments. The present study determines networks' shared and non-shared (specific) crucial elements in response to HCoV-229E and SARS-CoV-2 viruses to recommend candidate medications. METHODS: We retrieved the omics data on respiratory cells infected with HCoV-229E and SARS-CoV-2, constructed PPIN and GRN, and detected clusters and motifs. Using a drug-gene interaction network, we determined the similarities and disparities of mechanisms behind their host response and drug-repurposed. RESULTS: CXCL1, KLHL21, SMAD3, HIF1A, and STAT1 were the shared DEGs between both viruses' protein-protein interaction network (PPIN) and gene regulatory network (GRN). The NPM1 was a specific critical node for HCoV-229E and was a Hub-Bottleneck shared between PPI and GRN in HCoV-229E. The HLA-F, ADCY5, TRIM14, RPF1, and FGA were the seed proteins in subnetworks of the SARS-CoV-2 PPI network, and HSPA1A and RPL26 proteins were the seed in subnetworks of the PPI network of HCOV-229E. TRIM14, STAT2, and HLA-F played the same role for SARS-CoV-2. Top enriched KEGG pathways included cell cycle and proteasome in HCoV-229E and RIG-I-like receptor, Chemokine, Cytokine-cytokine, NOD-like receptor, and TNF signaling pathways in SARS-CoV-2. We suggest some candidate medications for COVID-19 patient lungs, including Noscapine, Isoetharine mesylate, Cycloserine, Ethamsylate, Cetylpyridinium, Tretinoin, Ixazomib, Vorinostat, Venetoclax, Vorinostat, Ixazomib, Venetoclax, and epoetin alfa for further in-vitro and in-vivo investigations. CONCLUSION: We suggested CXCL1, KLHL21, SMAD3, HIF1A, and STAT1, ADCY5, TRIM14, RPF1, and FGA, STAT2, and HLA-F as critical genes and Cetylpyridinium, Cycloserine, Noscapine, Ethamsylate, Epoetin alfa, Isoetharine mesylate, Ribavirin, and Tretinoin drugs to study further their importance in treating COVID-19 lung complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningSARS-CoV-2Protein Interaction MapsSystems BiologyCoronavirus 229E, HumanAntiviral AgentsHumansCOVID-19 Drug TreatmentNucleophosminRespiratory MucosaGene Regulatory NetworksCOVID-19

Stichwörter der Autor:innen

CoronavirusHCoV-229ELungProtein-protein interaction networkSARS-CoV-2Systems biology

Substanzen

Antiviral AgentsNucleophosminNPM1 protein, human

Autor:innen und Institutionen

  • Department of Comparative Biomedical Sciences, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Student Research Committee, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Comparative Biomedical Sciences, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran. aderakhshanfar@yahoo.com.
  • Center of Comparative and Experimental Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. aderakhshanfar@yahoo.com.

Zitieren

APA

Dehghan, Z., Mirmotalebisohi, S. A., Mozafar, M., Sameni, M., Saberi, F., Derakhshanfar, A., Moaedi, J., Zohrevand, H., & Zali, H. (2024). Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach. DARU Journal of Pharmaceutical Sciences. https://doi.org/10.1007/s40199-024-00507-0

Vancouver

Dehghan Z, Mirmotalebisohi SA, Mozafar M, Sameni M, Saberi F, Derakhshanfar A, et al. Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach. DARU Journal of Pharmaceutical Sciences. 2024. doi:10.1007/s40199-024-00507-0

BibTeX
@article{Dehghan2024,
  author = {Dehghan, Zeinab and Mirmotalebisohi, Seyed Amir and Mozafar, Maryam and Sameni, Marzieh and Saberi, Fatemeh and Derakhshanfar, Amin and Moaedi, Javad and Zohrevand, Hassan and Zali, Hakimeh},
  title = {Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach},
  journal = {DARU Journal of Pharmaceutical Sciences},
  year = {2024},
  doi = {10.1007/s40199-024-00507-0}
}
Kostenlos starten →